Live feed
Filing
SC 13D/A
SC 13D/A0001144204-17-027053·EAGLE PHARMACEUTICALS, INC.
Schedule 13D ownership disclosure
EAGLE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 269796108
Event date: 2017-05-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-027053
- Form type
- SC 13D/A
- Filer
- EAGLE PHARMACEUTICALS, INC.
- CIK
- CIK 827871
- Filed
- May 15, 2017
- Reporting period
- May 15, 2017
- Description
- Schedule 13D beneficial ownership